Thus, we proposed that distinct expression levels of these cytokines may reflect their potential immune regulatory properties and synergistic interactions of cytokine networks in part via IL-17 signaling pathway. Moreover, the kinetics of cytokine products may serve as critical homeostatic factors in

inflammatory “context” to determine the direction of tumor progression to some extent. In the present study, IL-17 expression level was not increased significantly. We speculated that compared with the circulating factors, fertile liver tissues (soil) endowed with abundant activated inflammatory/immune cells may play a more important role to determine IL-17 as a protumoral selleck inhibitor component. Obviously, numerous cytokines or growth factors involved in IL-17 pathway also need to be investigated such as IL-1, IL-23, TGF-β. In the absence of commercial human IL-17RE ELISA kit, we did not detect its expression in serum. Further study is required in our future research. Despite several substantive studies [10, 17] have confirmed the MK-8931 crosstalk with several types of inflammatory/immune cells contributed

to the protumor power of Th17 (a major source of IL-17), knowledge of their interaction in HCC is still incomplete. In a recent study [20], we demonstrated HSCs were the vital inflammatory cells selleck chemicals involved in the recurrence of HCC and could produce cytokines (IL-6 and TNF-α) to create a cytokine milieu

that benefited the expansion of human Th17 cells [17]. Moreover, our recent gene expression profile of HSCs confirmed several IL-17 receptors (e.g. IL-17RA, RB and RE) were expressed in HSCs (data not shown). Inasmuch very as the function of HSCs as liver-resident antigen-presenting cells [32], we identified the phenotypic features of IL-17 producing CD4+ T cells with the influence of HSCs in vitro. Interestingly, our present investigation provided evidence that secretions of activated human HSCs induced in vitro expansion of IL-17+ CD4+ T cells in HCC. In contrast, a recent data indicated suppressing Th17 differentiation by mouse HSCs [23]. Several aspects may contribute to this discrepancy. The first could be the different species (human vs mouse). Second, we used conditioned medium of HSCs, not per se HSCs, in order to eliminate the effects of other T cells on HSCs and subsequently feedback responses. Third, activation of HSCs can led to the loss of retinoic acid (RA) [33] which has already been identified as a key regulator to inhibit the generation of Th17 [34]. Therefore, absence of RA and in vitro activation made human HSCs appear to be fibroblast-like cells which were addressed to promote the expansion of Th17 [35].